Eric Swalwell sold Nektar Therapeutics (NASDAQ: NKTR)
Eric Swalwell (D-CA), a U.S. Representative, has disclosed 1 trade in Nektar Therapeutics (NKTR) since 2015, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Eric Swalwell sold $1,000 - $15,000 of Nektar Therapeutics (NASDAQ: NKTR) on April 1, 2015. Since that trade, NKTR is down -54.93% against the S&P 500 up +339.07%, an outperformance of -394.00%.
Data updated
Eric Swalwell's NKTR trades vs the price
NKTR is down -54.93% since Eric Swalwell sold on April 1, 2015, versus +339.07% for the S&P 500.
Performance since this trade
All Eric Swalwell NKTR trades
Eric Swalwell & NKTR trading FAQ
Is it legal for Eric Swalwell to trade Nektar Therapeutics (NKTR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Nektar Therapeutics (NKTR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Eric Swalwell sell NKTR?
Eric Swalwell disclosed a sale of $1,000 - $15,000 of Nektar Therapeutics (NKTR) on April 1, 2015, according to public STOCK Act filings.
How has NKTR performed since Eric Swalwell's trade?
Since Eric Swalwell sold NKTR on April 1, 2015, the stock is down -54.93%, versus +339.07% for the S&P 500 over the same period, an outperformance of -394.00%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NKTR trades?
BullishWhales tracks every disclosed congressional trade in Nektar Therapeutics (NKTR) on the Nektar Therapeutics congressional trading page, which aggregates filings across all members of Congress.
Eric Swalwell's NKTR tradesAll congressional filings for Nektar TherapeuticsEric Swalwell's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.